# The Prothrombotic Phenotype of Thirdhand Electronic Cigarette Exposure is Sex Independent and Involves Systemic Mediated Effects on Platelet Function: Evidence from a Mouse Model

**Authors:** Shelby S. Umphres, Ahmed B. Alarabi, Hamdy E. A. Ali, Shahnaz Qadri, Fadi T. Khasawneh, Fatima Z. Alshbool

PMC · DOI: 10.1007/s12012-026-10093-z · Cardiovascular Toxicology · 2026-02-17

## TL;DR

Thirdhand electronic cigarette exposure increases blood clot risk in mice, affecting both sexes equally through systemic inflammation.

## Contribution

First study showing THEC exposure causes a prothrombotic phenotype in mice, independent of sex.

## Key findings

- THEC exposure leads to hyperactive platelets with increased aggregation and granule secretion.
- Systemic effects of THEC are mediated through changes in cytokine profiles.
- Platelet reactivity is enhanced even when platelets are exposed to THEC-affected plasma alone.

## Abstract

Electronic cigarettes (e-cigs) are major contributors to inflammatory-mediated responses, which are implicated in a vast array of pathophysiological conditions, including cardiovascular disease (CVD). More recently e-cigs have been recognized as a source of thirdhand exposure (THEC); the process by which expelled toxins settle on materials (i.e., carpets, curtains, clothes etc.) and undergo chemical reactions, rendering them more harmful overtime. Herein, mice were exposed to THEC for four months, and platelet reactivity, systemic mediated effects on platelet function, and cytokine expression profiles were analyzed in both sexes. Our data revealed a hyperactive platelet phenotype as determined by shortened bleeding and occlusion times, enhanced platelet aggregation, and dense granule secretion with no significant difference between males and females. Cytokines, amongst other inflammatory molecules, are well documented mediators by which platelet function is modulated and they also enhance susceptibility to CVD. To this end, and to elucidate the mechanism by which platelet reactivity was augmented, washed platelets that were exposed only to clean air (CA) and resuspended in THEC exposed plasma, displayed significantly increased platelet aggregation, dense granule secretion, and p-selectin expression. Indeed, this data suggests that THEC exposure elicits a systemic effect, enhancing platelet response, and was further validated by a dysregulated cytokine profile using plasma, free of platelets, in a sex-dependent manner. Collectively and for the first time, we highlight that both males and females are at similar risk of THEC-mediated prothrombotic phenotype, which is underlined-at least in part- by an indirect systemic effect of exposure on platelet reactivity that involves changes in the cytokine profile. These findings underscore this form of exposure as a threat to cardiovascular health.

## Linked entities

- **Diseases:** cardiovascular disease (MONDO:0004995)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Mok (MOK protein kinase) [NCBI Gene 26448] {aka RAGE1, Rage, Stk30}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}, Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, Lif (leukemia inhibitory factor) [NCBI Gene 16878], Il22 (interleukin 22) [NCBI Gene 50929] {aka IL-22, IL-22a, ILTIFa, If2b1, Iltif}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, Cxcl2 (C-X-C motif chemokine ligand 2) [NCBI Gene 20310] {aka CINC-2a, GROb, Gro2, MIP-2, MIP-2a, Mgsa-b}, F2 (coagulation factor II) [NCBI Gene 14061] {aka Cf-2, Cf2, FII}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Tymp (thymidine phosphorylase) [NCBI Gene 72962] {aka 2900072D10Rik, Ecgf1, PD-ECGF, PDECGF, Pdgfec, TP}, Cd40 (CD40 antigen) [NCBI Gene 21939] {aka Bp50, GP39, HIGM1, IGM, IMD3, T-BAM}, Cxcl9 (C-X-C motif chemokine ligand 9) [NCBI Gene 17329] {aka CMK, Mig, MuMIG, Scyb9, crg-10}, Ldlr (low density lipoprotein receptor) [NCBI Gene 16835] {aka Hlb301}, Il7 (interleukin 7) [NCBI Gene 16196] {aka A630026I06Rik, Il-7, hlb368}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, tp (taupe) [NCBI Gene 21978], Postn (periostin, osteoblast specific factor) [NCBI Gene 50706] {aka A630052E07Rik, OSF-2, Osf2, PLF, PN}, Itga2b (integrin alpha 2b) [NCBI Gene 16399] {aka CD41, CD41B, GpIIb, alphaIIb}, Il3 (interleukin 3) [NCBI Gene 16187] {aka BPA, Csfmu, HCGF, Il-3, MCGF, PSF}, Dlk1 (delta like non-canonical Notch ligand 1) [NCBI Gene 13386] {aka DLK-1, DlkI, FA1, Ly107, Peg9, SCP1}, Lcn2 (lipocalin 2) [NCBI Gene 16819] {aka 24p3, NRL, Sip24}, Fgf21 (fibroblast growth factor 21) [NCBI Gene 56636] {aka Fgf8c}, Cd160 (CD160 antigen) [NCBI Gene 54215] {aka By55}, Crp (C-reactive protein, pentraxin-related) [NCBI Gene 12944], Havcr1 (hepatitis A virus cellular receptor 1) [NCBI Gene 171283] {aka KIM-1, TIM-1, Tim1, Timd1}, Cxcl13 (C-X-C motif chemokine ligand 13) [NCBI Gene 55985] {aka 4631412M08Rik, ANGIE2, Angie, BCA-1, BLC, BLR1L}, Ccl3 (C-C motif chemokine ligand 3) [NCBI Gene 20302] {aka G0S19-1, LD78alpha, MIP-1alpha, MIP1-(a), MIP1-alpha, Mip1a}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Areg (amphiregulin) [NCBI Gene 11839] {aka AR, Mcub, Sdgf}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, Il5 (interleukin 5) [NCBI Gene 16191] {aka Il-5}, Ccl5 (C-C motif chemokine ligand 5) [NCBI Gene 20304] {aka MuRantes, RANTES, SISd, Scya5, TCP228}, Ccl4 (C-C motif chemokine ligand 4) [NCBI Gene 20303] {aka AT744.1, Act-2, MIP-1B, Mip1b, Scya4}, Il11 (interleukin 11) [NCBI Gene 16156] {aka IL-11}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Il27 (interleukin 27) [NCBI Gene 246779] {aka IL-27, IL-27-A, IL-27p28, IL27-A, Il30, p28}, Tnfsf13b (tumor necrosis factor (ligand) superfamily, member 13b) [NCBI Gene 24099] {aka BAFF, BLyS, D8Ertd387e, TALL-1, TALL1, THANK}, Flt3 (FMS-like tyrosine kinase 3) [NCBI Gene 14255] {aka B230315G04, CD135, Flk-2, Flk2, Flt-3, Ly72}, Bcap31 (B cell receptor associated protein 31) [NCBI Gene 27061] {aka Bap31}, Angpt1 (angiopoietin 1) [NCBI Gene 11600] {aka 1110046O21Rik, Ang-1, Ang1}, Ccl20 (C-C motif chemokine ligand 20) [NCBI Gene 20297] {aka CKb4, LARC, MIP-3A, MIP-3[a], MIP3A, ST38}, Selp (selectin, platelet) [NCBI Gene 20344] {aka CD62P, GMP-140, Grmp, LECAM3, PADGEM}
- **Diseases:** heart attack (MESH:D009203), CVD (MESH:D002318), death (MESH:D003643), Thrombosis (MESH:D013927), impaired CV functions (MESH:D003072), thromboembolic diseases (MESH:D013923), cardiac depression (MESH:D006331), macular degeneration (MESH:D008268), inflammation (MESH:D007249), Platelet aggregation (MESH:D001791), carotid artery injury (MESH:D020212), bradyarrhythmia (MESH:D001919), stroke (MESH:D020521), Bleeding (MESH:D006470)
- **Chemicals:** PG (MESH:D019946), Nicotine (MESH:D009538), polyester (MESH:D011091), sodium citrate (MESH:D000077559), glycerin (MESH:D005990), CA (-), saponin (MESH:D012503), PBS (MESH:D007854), Alcohol (MESH:D000438), Cotinine (MESH:D003367), lipids (MESH:D008055), paraformaldehyde (MESH:C003043), TRITC (MESH:C009434), ATP (MESH:D000255), EGTA (MESH:D004533), FeCl3 (MESH:C024555), Menthol (MESH:D008610), FITC (MESH:D016650), avertin (MESH:C062527), phalloidin (MESH:D010590), sodium chloride (MESH:D012965), calcium chloride (MESH:D002122), PGI2 (MESH:D011464), isoflurane (MESH:D007530), e (MESH:D004540)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913280/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913280/full.md

---
Source: https://tomesphere.com/paper/PMC12913280